CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To test TKI effect, we salvaged CD34+ cells derived from the CB-iPSCs and CML-iPSCs and incubated them with or without imatinib (5 μM) in hematopoietic medium.